Wybrane aspekty genotypowania wrodzonego obrzȩku naczynioruchowego w erze NGS: Gen F12

Translated title of the contribution: Aspects of hereditary angioedema genotyping in the era of NGS: The case of F12 gene

Sofia Vatsiou, Maria Zamanakou, Gedeon Loules, Teresa González-Quevedo, Grzegorz Porȩbski, Aldona Juchacz, Maria Bova, Chiara Suffritti, Davide Firinu, Dorottya Csuka, Emmanouil Manousakis, Anna Valerieva, Maria Staevska, Markus Magerl, H. Farkas, Anastasios E. Germenis

Research output: Contribution to journalArticle

Abstract

Objective. To screen a cohort of patients diagnosed with non-FXII angioedema for carriage of variants of F12 gene. Material and methods. DNA samples from 191 patients suffering from primary angioedema with normal C1-INH, 54 samples from non- -affected family members, and 161 samples from C1-INH-HAE (154 type I, 7 type II) patients were included in the study. The F12 gene was genotyped by targeted NGS (100% coverage of translated regions). Sanger sequencing was performed for the verification of all identified variants and family segregation studies. Results. The pathogenic F12 variant c.983C>A was detected in three patients from two unrelated families initially diagnosed as U-HAE. Six additional mutations were identified, four of which were characterized as benign (c.41T>C, c.418C>G, c.1025C>T, c.530C>T) and two of uncertain significance (c.1530G>C, c.1768T>G). Two synonymous variants (c.756C>T and c.711C>T), the common polymorphism c.619G>C, and the functional polymorphism c.-4T>C were detected in allele frequencies similar to those presented in the ExAC database for the European population. One more not yet reported synonymous variant (c. 1599A>G) was also found. Conclusion. Analyzing the entire translated region of F12 gene is important in order to identify new variants that possibly affect HAE expressivity. Interestingly, genetic analysis of F12 supports not only the diagnosis of FXII-HAE but also the correct exclusion diagnosis of U-HAE.

Original languagePolish
Pages (from-to)205-210
Number of pages6
JournalAlergia Astma Immunologia
Volume23
Issue number4
Publication statusPublished - Dec 1 2018

Fingerprint

Hereditary Angioedemas
Angioedema
Genes
Gene Frequency
Databases
Mutation
DNA
Population

Keywords

  • F12 gene
  • F12 mutations
  • Hereditary angioedema
  • Next-generation sequencing

ASJC Scopus subject areas

  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine

Cite this

Vatsiou, S., Zamanakou, M., Loules, G., González-Quevedo, T., Porȩbski, G., Juchacz, A., ... Germenis, A. E. (2018). Wybrane aspekty genotypowania wrodzonego obrzȩku naczynioruchowego w erze NGS: Gen F12. Alergia Astma Immunologia, 23(4), 205-210.

Wybrane aspekty genotypowania wrodzonego obrzȩku naczynioruchowego w erze NGS : Gen F12. / Vatsiou, Sofia; Zamanakou, Maria; Loules, Gedeon; González-Quevedo, Teresa; Porȩbski, Grzegorz; Juchacz, Aldona; Bova, Maria; Suffritti, Chiara; Firinu, Davide; Csuka, Dorottya; Manousakis, Emmanouil; Valerieva, Anna; Staevska, Maria; Magerl, Markus; Farkas, H.; Germenis, Anastasios E.

In: Alergia Astma Immunologia, Vol. 23, No. 4, 01.12.2018, p. 205-210.

Research output: Contribution to journalArticle

Vatsiou, S, Zamanakou, M, Loules, G, González-Quevedo, T, Porȩbski, G, Juchacz, A, Bova, M, Suffritti, C, Firinu, D, Csuka, D, Manousakis, E, Valerieva, A, Staevska, M, Magerl, M, Farkas, H & Germenis, AE 2018, 'Wybrane aspekty genotypowania wrodzonego obrzȩku naczynioruchowego w erze NGS: Gen F12', Alergia Astma Immunologia, vol. 23, no. 4, pp. 205-210.
Vatsiou S, Zamanakou M, Loules G, González-Quevedo T, Porȩbski G, Juchacz A et al. Wybrane aspekty genotypowania wrodzonego obrzȩku naczynioruchowego w erze NGS: Gen F12. Alergia Astma Immunologia. 2018 Dec 1;23(4):205-210.
Vatsiou, Sofia ; Zamanakou, Maria ; Loules, Gedeon ; González-Quevedo, Teresa ; Porȩbski, Grzegorz ; Juchacz, Aldona ; Bova, Maria ; Suffritti, Chiara ; Firinu, Davide ; Csuka, Dorottya ; Manousakis, Emmanouil ; Valerieva, Anna ; Staevska, Maria ; Magerl, Markus ; Farkas, H. ; Germenis, Anastasios E. / Wybrane aspekty genotypowania wrodzonego obrzȩku naczynioruchowego w erze NGS : Gen F12. In: Alergia Astma Immunologia. 2018 ; Vol. 23, No. 4. pp. 205-210.
@article{6ad9675531ae49f8aa20f31be8afee3f,
title = "Wybrane aspekty genotypowania wrodzonego obrzȩku naczynioruchowego w erze NGS: Gen F12",
abstract = "Objective. To screen a cohort of patients diagnosed with non-FXII angioedema for carriage of variants of F12 gene. Material and methods. DNA samples from 191 patients suffering from primary angioedema with normal C1-INH, 54 samples from non- -affected family members, and 161 samples from C1-INH-HAE (154 type I, 7 type II) patients were included in the study. The F12 gene was genotyped by targeted NGS (100{\%} coverage of translated regions). Sanger sequencing was performed for the verification of all identified variants and family segregation studies. Results. The pathogenic F12 variant c.983C>A was detected in three patients from two unrelated families initially diagnosed as U-HAE. Six additional mutations were identified, four of which were characterized as benign (c.41T>C, c.418C>G, c.1025C>T, c.530C>T) and two of uncertain significance (c.1530G>C, c.1768T>G). Two synonymous variants (c.756C>T and c.711C>T), the common polymorphism c.619G>C, and the functional polymorphism c.-4T>C were detected in allele frequencies similar to those presented in the ExAC database for the European population. One more not yet reported synonymous variant (c. 1599A>G) was also found. Conclusion. Analyzing the entire translated region of F12 gene is important in order to identify new variants that possibly affect HAE expressivity. Interestingly, genetic analysis of F12 supports not only the diagnosis of FXII-HAE but also the correct exclusion diagnosis of U-HAE.",
keywords = "F12 gene, F12 mutations, Hereditary angioedema, Next-generation sequencing",
author = "Sofia Vatsiou and Maria Zamanakou and Gedeon Loules and Teresa Gonz{\'a}lez-Quevedo and Grzegorz Porȩbski and Aldona Juchacz and Maria Bova and Chiara Suffritti and Davide Firinu and Dorottya Csuka and Emmanouil Manousakis and Anna Valerieva and Maria Staevska and Markus Magerl and H. Farkas and Germenis, {Anastasios E.}",
year = "2018",
month = "12",
day = "1",
language = "Polish",
volume = "23",
pages = "205--210",
journal = "Alergia Astma Immunologia",
issn = "1427-3101",
publisher = "University School of Medicine of Lodz",
number = "4",

}

TY - JOUR

T1 - Wybrane aspekty genotypowania wrodzonego obrzȩku naczynioruchowego w erze NGS

T2 - Gen F12

AU - Vatsiou, Sofia

AU - Zamanakou, Maria

AU - Loules, Gedeon

AU - González-Quevedo, Teresa

AU - Porȩbski, Grzegorz

AU - Juchacz, Aldona

AU - Bova, Maria

AU - Suffritti, Chiara

AU - Firinu, Davide

AU - Csuka, Dorottya

AU - Manousakis, Emmanouil

AU - Valerieva, Anna

AU - Staevska, Maria

AU - Magerl, Markus

AU - Farkas, H.

AU - Germenis, Anastasios E.

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Objective. To screen a cohort of patients diagnosed with non-FXII angioedema for carriage of variants of F12 gene. Material and methods. DNA samples from 191 patients suffering from primary angioedema with normal C1-INH, 54 samples from non- -affected family members, and 161 samples from C1-INH-HAE (154 type I, 7 type II) patients were included in the study. The F12 gene was genotyped by targeted NGS (100% coverage of translated regions). Sanger sequencing was performed for the verification of all identified variants and family segregation studies. Results. The pathogenic F12 variant c.983C>A was detected in three patients from two unrelated families initially diagnosed as U-HAE. Six additional mutations were identified, four of which were characterized as benign (c.41T>C, c.418C>G, c.1025C>T, c.530C>T) and two of uncertain significance (c.1530G>C, c.1768T>G). Two synonymous variants (c.756C>T and c.711C>T), the common polymorphism c.619G>C, and the functional polymorphism c.-4T>C were detected in allele frequencies similar to those presented in the ExAC database for the European population. One more not yet reported synonymous variant (c. 1599A>G) was also found. Conclusion. Analyzing the entire translated region of F12 gene is important in order to identify new variants that possibly affect HAE expressivity. Interestingly, genetic analysis of F12 supports not only the diagnosis of FXII-HAE but also the correct exclusion diagnosis of U-HAE.

AB - Objective. To screen a cohort of patients diagnosed with non-FXII angioedema for carriage of variants of F12 gene. Material and methods. DNA samples from 191 patients suffering from primary angioedema with normal C1-INH, 54 samples from non- -affected family members, and 161 samples from C1-INH-HAE (154 type I, 7 type II) patients were included in the study. The F12 gene was genotyped by targeted NGS (100% coverage of translated regions). Sanger sequencing was performed for the verification of all identified variants and family segregation studies. Results. The pathogenic F12 variant c.983C>A was detected in three patients from two unrelated families initially diagnosed as U-HAE. Six additional mutations were identified, four of which were characterized as benign (c.41T>C, c.418C>G, c.1025C>T, c.530C>T) and two of uncertain significance (c.1530G>C, c.1768T>G). Two synonymous variants (c.756C>T and c.711C>T), the common polymorphism c.619G>C, and the functional polymorphism c.-4T>C were detected in allele frequencies similar to those presented in the ExAC database for the European population. One more not yet reported synonymous variant (c. 1599A>G) was also found. Conclusion. Analyzing the entire translated region of F12 gene is important in order to identify new variants that possibly affect HAE expressivity. Interestingly, genetic analysis of F12 supports not only the diagnosis of FXII-HAE but also the correct exclusion diagnosis of U-HAE.

KW - F12 gene

KW - F12 mutations

KW - Hereditary angioedema

KW - Next-generation sequencing

UR - http://www.scopus.com/inward/record.url?scp=85072814343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072814343&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85072814343

VL - 23

SP - 205

EP - 210

JO - Alergia Astma Immunologia

JF - Alergia Astma Immunologia

SN - 1427-3101

IS - 4

ER -